UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z
Number of items: 273.

A

Adams, J; Wickremasinghe, RG; Prentice, AG; Strefford, JC; Duncombe, A; Forconi, F; Stevenson, FK; ... Steele, A; + view all (2012) Phenethyl Isothiocyanate (PEITC) Regulates Autophagy in Chronic Lymphocytic Leukemia. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Agarwal, B; Wright, G; Gatt, A; Riddell, A; Vemala, V; Mallett, S; Chowdary, P; ... Burroughs, A; + view all (2012) Evaluation of coagulation abnormalities in acute liver failure. JOURNAL OF HEPATOLOGY , 57 (4) pp. 780-786. 10.1016/j.jhep.2012.06.020.

Agarwal, B; Wright, G; Gatt, A; Riddell, A; Vemala, V; Mallett, S; Chowdary, P; ... Burroughs, A; + view all (2012) Evaluation of coagulation abnormalities in acute liver failure. Journal of Hepatology , 57 (4) pp. 780-786. 10.1016/j.jhep.2012.06.020.

Agostinelli, C; Paterson, JC; Gupta, R; Righi, S; Sandri, F; Piccaluga, PP; Bacci, F; ... Marafioti, T; + view all (2012) Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. HISTOPATHOLOGY , 61 (1) pp. 33-46. 10.1111/j.1365-2559.2012.04198.x.

Aguiar Alpizar, Y; Karwacz, K; Arce, F; Yglesias Rivera, A; Enrique Fernandez, L; Collins, MK; Sanchez Ramirez, B; (2012) Lentiviral vector followed by protein immunisation breaks tolerance against the self-antigen Her1 and results in lung cancer immunotherapy. JOURNAL OF GENE MEDICINE , 14 (3) pp. 151-157. 10.1002/jgm.2606.

Aitchison, KL; Rahim, AA; Hughes, D; Kinnon, C; Waddington, SN; Howe, SJ; (2012) Developing lentiviral vectors for gene therapy of Type I Gaucher Disease. Presented at: Annual Conference of the British-Society-for-Gene-Therapy (BSGT), UCL Inst Child Hlth, London, ENGLAND.

Al-Thihli, K; Ebrahim, H; Hughes, DA; Patel, M; Tipple, M; Salvarinova, R; Gardiner, J; ... Waters, PJ; + view all (2012) A variant of unknown significance in the GLA gene causing diagnostic uncertainty in a young female with isolated hypertrophic cardiomyopathy. GENE , 497 (2) pp. 320-322. 10.1016/j.gene.2012.01.056.

Allen, CG; Tinsley, SP; Hills, RK; Evans, CM; Lamb, K; Sellar, RS; Sale, M; ... Gale, RE; + view all (2012) The impact of mutant level on clinical outcome in acute myeloid leukaemia differs according to the mutated gene. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 20). WILEY-BLACKWELL

Ameen, RM; Al Shemmari, SH; Luqmani, Y; Torres, HM; Marsh, SGE; (2012) HLA CLASS I AND CLASS II ALLELE FREQUENCIES AMONG KUWAITI ARAB BLOOD DONORS. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 556). WILEY-BLACKWELL

Arce, F; Kochan, G; Breckpot, K; Stephenson, H; Escors, D; (2012) Selective Activation of Intracellular Signalling Pathways in Dendritic Cells for Cancer Immunotherapy. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , 12 (1) pp. 29-39. 10.2174/187152012798764679.

Arrieta Bolanos, ER; Madrigal, J; Shaw, B; (2012) Functional consequences of TGFB1 polymorphisms in regulatory T cells and haematopoietic stem cell transplantation. Presented at: The Joint 16th International HLA and Immunogenetics Conference/26th European Immunogenetics and Histocompatibility Conference/23rd British Society of Histocompatibilty and Immunogenetics Conference, Liverpool, UK. Green open access
file

Arrieta Bolanos, ER; Madrigal, JA; Shaw, BE; (2012) Human Leukocyte Antigen Profiles of Latin American Populations: Differential Admixture and Its Potential Impact on Hematopoietic Stem Cell Transplantation. Bone Marrow Research , 2012 , Article 136087. 10.1155/2012/136087. Green open access
file

Arrieta Bolanos, ER; Madrigal, JA; Shaw, BE; Marsh, SGE; Salazar-Sánchez, L; (2012) The frequency of HLA-B*57:01 and the risk of Abacavir hypersensitivity reactions in the Costa Rica Central Valley Population. Presented at: The Joint 16th International HLA and Immunogenetics Conference/26th European Immunogenetics and Histocompatibility Conference/23rd British Society of Histocompatibilty and Immunogenetics Conference, Liverpool, UK. Green open access
file

Arrieta-Bolanos, E; Madrigal, JA; Shaw, BE; (2012) FUNCTIONAL CONSEQUENCES OF TGFB1 POLYMORPHISMS IN REGULATORY T CELLS AND HEMATOPOIETIC STEM CELL TRANSPLANTATION. Presented at: Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference, Liverpool, ENGLAND. Green open access
file

Arrieta-Bolanos, E; Madrigal, JA; Shaw, BE; (2012) Transforming growth factor-ss 1 polymorphisms and the outcome of hematopoietic stem cell transplantation. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 192-202. 10.1111/j.1744-313X.2012.01089.x.

Arrieta-Bolaños, E; Madrigal, JA; Shaw, BE; (2012) Transforming growth factor-β1 polymorphisms and the outcome of hematopoietic stem cell transplantation. Int J Immunogenet , 39 (3) pp. 192-202. 10.1111/j.1744-313X.2012.01089.x.

Artim-Esen, B; Pericleous, C; Mackie, I; Ioannou, Y; Rahman, A; Isenberg, DA; Giles, I; (2012) ANTI-Factor Xa Antibodies ARE Significantly Increased in Patients with Systemic LUPUS Erythematosus and Antiphospholipid Syndrome. In: (Proceedings) Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP). (pp. S739-S739). WILEY-BLACKWELL

Aydinok, Y; Evans, P; Manz, CY; Porter, JB; (2012) Timed non-transferrin bound iron determinations probe the origin of chelatable iron pools during deferiprone regimens and predict chelation response. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 97 (6) pp. 835-841. 10.3324/haematol.2011.056317.

B

Babb, A; Farah, N; Lyons, C; Lindsay, K; Reddy, N; Goldman, J; Apperley, JF; (2012) Uptake and outcome of assisted reproductive techniques in long-term survivors of SCT. Bone Marrow Transplant , 47 (4) pp. 568-573. 10.1038/bmt.2011.134.

Becerra, E; Leandro, MJ; Heelas, EO; Westwood, JP; de la Torre, I; Scully, MA; Cambridge, G; (2012) B Cell Activating Factor Receptor Expression After Rituximab: Comparison of Patients with Rheumatoid Arthritis and Thrombotic Thrombocytopenic Purpura. In: (Proceedings) Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP). (pp. S752-S752). WILEY-BLACKWELL

Benjamin, ER; Brignol, N; Young, B; Chang, HH; Khanna, R; Soska, R; Sitaraman, SA; ... Valenzano, KJ; + view all (2012) MIGALASTAT HCL REDUCES GLOBOTRIAOSYLSPHINGOSINE (LYSO-GB3) IN PLASMA OF FABRY PATIENTS AND IN TISSUES OF FABRY TRANSGENIC MICE. Presented at: UNSPECIFIED.

Bennett, CL; Chakraverty, R; (2012) Dendritic cells in tissues: in situ stimulation of immunity and immunopathology. Trends in Immunology , 33 (1) pp. 8-13. 10.1016/j.it.2011.09.008. Green open access
file

Biegstraaten, M; Wesnes, KA; Luzy, C; Petakov, M; Mrsic, M; Niederau, C; Giraldo, P; ... van Schaik, IN; + view all (2012) The cognitive profile of type 1 Gaucher disease patients. JOURNAL OF INHERITED METABOLIC DISEASE , 35 (6) pp. 1093-1099. 10.1007/s10545-012-9460-7.

Binny, C; McIntosh, J; Della Peruta, M; Kymalainen, H; Tuddenham, EGD; Buckley, SMK; Waddington, SN; ... Nathwani, AC; + view all (2012) AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage. BLOOD , 119 (4) 957 - 966. 10.1182/blood-2011-09-377630.

Bolton-Maggs, PHB; Chapman, C; Mistry, H; Williamson, L; Cohen, H; (2012) Continued absence of transfusion-associated graft versus host disease despite failures to provide irradiated products to patients at risk - more than a decade of data from SHOT. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 3-4). WILEY-BLACKWELL

Bolton-Maggs, PHB; Cohen, H; (2012) Serious hazards of transfusion haemovigilance - The UK experience. European Oncology and Haematology , 8 (2) pp. 127-129.

Brown, JH; Tellez, J; Wilson, V; Mackie, IJ; Scully, M; Tredger, MM; Moore, I; ... Goodship, THJ; + view all (2012) Postpartum aHUS Secondary to a Genetic Abnormality in Factor H Acquired Through Liver Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION , 12 (6) pp. 1632-1636. 10.1111/j.1600-6143.2012.03991.x.

C

Calleja-Agius, J; Jauniaux, E; Pizzey, AR; Muttukrishna, S; (2012) Investigation of systemic inflammatory response in first trimester pregnancy failure. HUMAN REPRODUCTION , 27 (2) pp. 349-357. 10.1093/humrep/der402.

Camilleri, RS; Scully, M; Thomas, M; Mackie, IJ; Liesner, R; Chen, WJ; Manns, K; (2012) A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 10 (9) pp. 1792-1801. 10.1111/j.1538-7836.2012.04852.x.

Camilleri, RS; Scully, M; Thomas, M; Mackie, IJ; Liesner, R; Chen, WJ; Manns, K; (2012) A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom. Journal of Thrombosis and Haemostasis , 10 (9) pp. 1792-1801. 10.1111/j.1538-7836.2012.04852.x.

Cappellini, MD; El-Beshlawy, A; Porter, JB; Kattamis, A; Taylor, K; Rose, C; Louw, VJ; ... Gattermann, N; + view all (2012) Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Carpenter, B; Ghorashian, S; Nicholson, E; Griffin, J; Ahmadi, M; Zhang, L; Holler, A; ... Chakraverty, R; + view all (2012) Targeting therapeutic T cells to tumour niches. In: (Proceedings) European Congress of Immunology. (pp. pp. 53-54). WILEY-BLACKWELL

Carpenter, B; Ghorashian, S; Nicholson, E; Griffin, JE; Ahmadi, M; Holler, A; Flutter, B; ... Chakraverty, R; + view all (2012) Targeting Therapeutic T Cells to Tumour Niches. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Cereb, N; Schmidt, A; Marsh, SGE; Ehninger, G; Yang, SY; (2012) NEW HLA ALLELES OBSERVED IN A LARGE NUMBER OF POTENTIAL BLOOD STEM CELL DONORS DETERMINED BY SEQUENCE BASED TYPING. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 450). WILEY-BLACKWELL

Chakraverty, R; (2012) Do educated natural killer cells make the grade in treating acute myeloid leukemia? HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 97 (11) p. 1617. 10.3324/haematol.2012.078717.

Chakraverty, R; Mackinnon, S; (2012) Allogeneic stem cell transplantation for lymphoma. In: Sweetenham, J and Abraham, J, (eds.) Emerging Cancer Therapeutics. Demos Medical Publishing

Chatterjee, R; Shah, FT; Davis, BA; Byers, M; Sooranna, D; Bajoria, R; Pringle, J; (2012) Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in beta-thalassaemia presenting with osteopenia-osteoporosis syndrome. BRITISH JOURNAL OF HAEMATOLOGY , 159 (4) pp. 462-471. 10.1111/bjh.12048.

Chiesa, R; Gilmour, K; Qasim, W; Adams, S; Worth, AJJ; Zhan, H; Montiel-Equihua, CA; ... Veys, P; + view all (2012) Omission of in vivo T-cell depletion promotes rapid expansion of naive CD4(+) cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. BRITISH JOURNAL OF HAEMATOLOGY , 156 (5) pp. 656-666. 10.1111/j.1365-2141.2011.08994.x.

Chiesa, R; Gilmour, K; Qasim, W; Adams, S; Worth, AJJ; Zhan, H; Montiel-Equihua, CA; ... Veys, P; + view all (2012) Omission of in vivo T-cell depletion promotes rapid expansion of naïve CD4+ cord blood lymphocytes and restores adaptive immunity within 2 months after unrelated cord blood transplant. Br J Haematol , 156 (5) pp. 656-666. 10.1111/j.1365-2141.2011.08994.x.

Coats, CJ; Paresi, V; Ramos, M; Janagarajan, K; O'Mahony, C; Dawnay, A; Mehta, A; ... Elliott, PM; + view all (2012) Role of serum NT-proBNP measurement in the diagnosis of early cardiac involvement in patients with anderson-fabry disease. Presented at: Congress of the European-Society-of-Cardiology (ESC), Munchen, GERMANY.

Cohen, H; Bolton-Maggs, P; (2012) Breaking records in blood transfusion safety. TRANSFUSION MEDICINE , 22 (4) pp. 241-243. 10.1111/j.1365-3148.2012.01174.x.

Cohen, H; Bolton-Maggs, PHB; Ball, J; Chapman, C; (2012) Too much blood, too quickly: avoiding hazards associated with transfusion-associated circulatory overload (TACO) identified by SHOT reporting. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 17). WILEY-BLACKWELL

Cohen, H; Mackie, IJ; Westwood, JP; Chitolie, A; Liesner, R; Machin, SJ; (2012) Prothrombin/phosphatidyl serine antibodies in patients with antiphospholipid antibodies. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 33-34). WILEY-BLACKWELL

Cohen, H; Williamson, LM; (2012) Setting up a National Hemovigilance System: SHOT. In: Hemovigilance: An Effective Tool for Improving Transfusion Safety. (pp. 168-179).

Cohen, H; Williamson, LM; (2012) SHOT UK: setting up a haemovigilance scheme. In: de Vries, R and Faber, JC and Robillard, P, (eds.) Haemovigilance. Blackwell-Wiley

Conlan, T; Sivakumaran, J; Fallah-Arani, F; Zhang, L; Means, T; Geissman, F; Chakraverty, R; (2012) Investigating the role of cutaneous dendritic cells in T-cell mediated immunopathology. In: (Proceedings) European Congress of Immunology. (pp. p. 479). WILEY-BLACKWELL

Cox, ST; Madrigal, JA; Saudemont, A; (2012) Three novel allelic variants of the RAET1E/ULBP4 gene in humans. TISSUE ANTIGENS , 80 (4) pp. 390-392. 10.1111/j.1399-0039.2012.01933.x.

D

Davidoff, A; Tuddenham, EGD; Rangarajan, S; Rosales, C; McIntosh, J; Chowdary, P; Riddell, A; ... Nathwani, AC; + view all (2012) Stable Factor IX Activity Following AAV-Mediated Gene Transfer in Patients with Severe Hemophilia B. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Delhove, JMKM; Waddington, SN; Ward, NJ; Jathoul, AP; Pule, MA; McKay, TR; Buckley, SMK; (2012) Development of bicistronic lentiviral vectors for continual in vivo and endpoint analysis of gene and stem cell transfer. In: (Proceedings) Annual Conference of the British-Society-for-Gene-Therapy (BSGT). (pp. A11-A12). MARY ANN LIEBERT INC

Della Peruta, M; Binny, C; Nathwani, D; McIntosh, J; Rosales, C; Davidoff, AM; Williams, R; ... Nathwani, AC; + view all (2012) DEVELOPMENT OF A LIVER-SPECIFIC, TUMOUR-SELECTIVE RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR TO TARGET HEPATOCELLULAR CARCINOMA. In: (Proceedings) 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL). (pp. S111-S111). ELSEVIER SCIENCE BV

Della Peruta, M; Binny, C; Nathwani, D; McIntosh, J; Rosales, C; Davidoff, AM; Williams, R; ... Nathwani, AC; + view all (2012) DEVELOPMENT OF A LIVER-SPECIFIC, TUMOUR-SELECTIVE RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR TO TARGET HEPATOCELLULAR CARCINOMA. GUT , 61 A201-A201. 10.1136/gutjnl-2012-302514c.43.

Dey, A; Zhang, Y; Castleton, A; Patel, B; Ghorani, E; Rai, L; Elham, M; (2012) Polymorphonuclear Neutrophils(PMNs) Are Cytotoxic for Measles Virus (MV)-Infected Tumor Cells Ex-Vivo, but Their Role in MV-Mediated Oncolysis In-Vivo Is Tumor-Type Dependent. In: (Proceedings) 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S271-S271). NATURE PUBLISHING GROUP

Dignan, FL; Amrolia, P; Clark, A; Cornish, J; Jackson, G; Mahendra, P; Scarisbrick, JJ; ... British Society for Blood and Marrow Transplantation, ; + view all (2012) Diagnosis and management of chronic graft-versus-host disease. Br J Haematol , 158 (1) pp. 46-61. 10.1111/j.1365-2141.2012.09128.x.

Dignan, FL; Clark, A; Amrolia, P; Cornish, J; Jackson, G; Mahendra, P; Scarisbrick, JJ; ... Potter, MN; + view all (2012) Diagnosis and management of acute graft-versus-host disease. British Journal of Haematology

Dignan, FL; Clark, A; Amrolia, P; Cornish, J; Jackson, G; Mahendra, P; Scarisbrick, JJ; ... British Society for Blood and Marrow Transplantation, ; + view all (2012) Diagnosis and management of acute graft-versus-host disease. Br J Haematol , 158 (1) pp. 30-45. 10.1111/j.1365-2141.2012.09129.x.

Dignan, FL; Greenblatt, D; Cox, M; Cavenagh, J; Oakervee, H; Apperley, JF; Fielding, AK; ... Scarisbrick, JJ; + view all (2012) Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. BONE MARROW TRANSPLANTATION , 47 (6) pp. 824-830. 10.1038/bmt.2011.186.

Dignan, FL; Greenblatt, D; Cox, M; Cavenagh, J; Oakervee, H; Apperley, JF; Fielding, AK; ... Scarisbrick, JJ; + view all (2012) Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplantation , 47 (6) pp. 824-830. 10.1038/bmt.2011.186.

Dignan, FL; Scarisbrick, JJ; Cornish, J; Clark, A; Amrolia, P; Jackson, G; Mahendra, P; ... Shaw, BE; + view all (2012) Organ-specific management and supportive care in chronic graft-versus-host disease. BRITISH JOURNAL OF HAEMATOLOGY , 158 (1) pp. 62-78. 10.1111/j.1365-2141.2012.09131.x.

Direkze, S; Mansour, M; Rodriguez-Justo, M; Kibbler, C; Gant, V; Peggs, KS; (2012) Candida kefyr fungal enteritis following autologous BMT. BONE MARROW TRANSPLANTATION , 47 (3) pp. 465-466. 10.1038/bmt.2011.112.

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AHV; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. MOLECULAR GENETICS AND METABOLISM , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006. Gold open access

Duran, R; McNeill, A; Mehta, A; Hughes, D; Cox, T; Deegan, P; Schapira, AHV; (2012) Novel pathogenic mutations in the glucocerebrosidase locus. Molecular Genetics and Metabolism , 106 (4) pp. 495-497. 10.1016/j.ymgme.2012.05.006.

de Groot, NG; Otting, N; Robinson, J; Blancher, A; Lafont, BAP; Marsh, SGE; O'Connor, DH; ... Bontrop, RE; + view all (2012) Nomenclature report on the major histocompatibility complex genes and alleles of Great Ape, Old and New World monkey species. IMMUNOGENETICS , 64 (8) pp. 615-631. 10.1007/s00251-012-0617-1.

de Gruijl, TD; Ginhoux, F; Bousso, P; Bieber, T; Piguet, V; von Stebut, E; Dudziak, D; (2012) Fondation rene touraine pour la dermatologie. Exp Dermatol , 21 (10) pp. 802-814. 10.1111/exd.12000.

E

Ebrahim, HY; Baker, RJ; Mehta, AB; Hughes, DA; (2012) Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T). JOURNAL OF INHERITED METABOLIC DISEASE , 35 (2) pp. 325-334. 10.1007/s10545-011-9395-4.

El-Andaloussi, S; Lee, Y; Lakhal-Littleton, S; Li, J; Seow, Y; Gardiner, C; Alvarez-Erviti, L; ... Wood, MJA; + view all (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. NATURE PROTOCOLS , 7 (12) pp. 2112-2126. 10.1038/nprot.2012.131.

El-Andaloussi, S; Lee, Y; Lakhal-Littleton, S; Li, J; Seow, Y; Gardiner, C; Alvarez-Erviti, L; ... Wood, MJA; + view all (2012) Exosome-mediated delivery of siRNA in vitro and in vivo. Nature Protocols , 7 (12) pp. 2112-2126. 10.1038/nprot.2012.131.

El-Sharkawi, D; Ali, A; Evans, CM; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2012) ASXL1 mutations are infrequent in young patients with primary acute myeloid leukaemia. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 56). WILEY-BLACKWELL

El-Sharkawi, D; Fisher, C; Khambadkone, S; Stephens, AD; Porter, JB; (2012) SECONDARY ERYTHROCYTOSIS DUE TO COMPOUND HOMOZYGOSITY, BUT NOT COMPOUND HETEROZYGOSITY, FOR Hb LUTON AND alpha-THALASSEMIA: A FAMILY STUDY. HEMOGLOBIN , 36 (1) pp. 7-17. 10.3109/03630269.2011.641134.

Elliott, MJ; De Coppi, P; Speggiorin, S; Roebuck, D; Butler, CR; Samuel, E; Crowley, C; ... Birchall, MA; + view all (2012) Stem-cell-based, tissue engineered tracheal replacement in a child: A 2-year follow-up study. The Lancet , 380 (9846) pp. 994-1000. 10.1016/S0140-6736(12)60737-5.

Elliott, MJ; De Coppi, P; Speggiorin, S; Roebuck, D; Butler, CR; Samuel, E; Crowley, C; ... Birchall, MA; + view all (2012) Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. LANCET , 380 (9846) pp. 994-1000. 10.1016/S0140-6736(12)60737-5.

Erkan, D; Rahman, A; Cohen, H; Machin, SJ; Pierangeli, SS; (2012) What are the potential future treatments in antiphospholipid syndrome? In: Antiphospholipid Syndrome: Insights and Highlights from the 13Th International Congress on Antiphospholipid Antibodies. (pp. 261-287).

F

FOLEY, JH; NESHEIM, ME; RIVARD, GE; BRUMMEL-ZIEDINS, KE; (2012) Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A. Haemophilia , 18 (3) e316-e322. 10.1111/j.1365-2516.2011.02648.x.

Fagone, P; Wright, JF; Nathwani, AC; Nienhuis, AW; Davidoff, AM; Gray, JT; (2012) Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods. HUMAN GENE THERAPY METHODS , 23 (1) pp. 1-7. 10.1089/hgtb.2011.104.

Ferrer, IR; Liu, D; Pinelli, DF; Koehn, BH; Stempora, LL; Ford, ML; (2012) CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules. J Immunol , 189 (9) pp. 4387-4395. 10.4049/jimmunol.1201757.

Ferrer, IR; Wagener, ME; Song, M; Ford, ML; (2012) CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. PLoS One , 7 (7) , Article e40559. 10.1371/journal.pone.0040559.

Fielding, AK; Banerjee, L; Marks, DI; (2012) Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma. CURRENT HEMATOLOGIC MALIGNANCY REPORTS , 7 (2) pp. 160-169. 10.1007/s11899-012-0123-4.

Fields, P; Townsend, WM; Webb, A; Pocock, CFE; Smith, P; Kirkwood, A; El-Mehidi, N; ... Cunningham, D; + view all (2012) First analysis of a phase II multicentre trial of rituximab, gemcitabine, cyclophosphamide, vincristine and prednisolone (R-GCVP) for patients with newly diagnosed diffuse large B cell lymphoma (DLBCL) considered unsuitable for anthracycline containing chemo-immunotherapy. An NCRI lymphoma clinical studies group trial. CRUK/07/007. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 13-14). WILEY-BLACKWELL

Fields, PA; Linch, DC; (2012) Treatment of the elderly patient with diffuse large B cell lymphoma. Br J Haematol , 157 (2) pp. 159-170. 10.1111/j.1365-2141.2011.09011.x.

Fleischhauer, K; Shaw, BE; Gooley, T; Malkki, M; Bardy, P; Bignon, J-D; Dubois, V; ... International Histocompatibility Working Group in Hematopoietic , ; + view all (2012) Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol , 13 (4) pp. 366-374. 10.1016/S1470-2045(12)70004-9.

Fleischhauer, K; Shaw, BE; Gooley, T; Malkki, M; Bardy, P; Bignon, JD; Dubois, V; ... Petersdorf, EW; + view all (2012) Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: A retrospective study. The Lancet Oncology , 13 (4) pp. 366-374. 10.1016/S1470-2045(12)70004-9.

Foley, JH; Butenas, S; Mann, KG; Brummel-Ziedins, KE; (2012) Measuring the mechanical properties of blood clots formed via the tissue factor pathway of coagulation. Analytical Biochemistry , 422 (1) pp. 46-51. 10.1016/j.ab.2011.12.036.

Foley, JH; Ferris, L; Brummel-Ziedins, KE; (2012) Characteristics of Fibrin Formation and Clot Stability in Individuals with Congenital Type IIb Protein C Deficiency. Thrombosis Research , 129 (4) e142-e146. 10.1016/j.thromres.2011.12.020.

Foley, JH; Petersen, K-U; Rea, CJ; Harpell, L; Powell, S; Lillicrap, D; Nesheim, ME; (2012) Solulin increases clot stability in whole blood from humans and dogs with hemophilia. Blood , 119 (15) pp. 3622-3628. 10.1182/blood-2011-11-392308.

Forrester, AM; Berman, JN; Payne, EM; (2012) Myelopoiesis and Myeloid Leukaemogenesis in the Zebrafish. Advances in Hematology , 2012 , Article 358518. 10.1155/2012/358518. Green open access
file

G

Galarza, FFG; Marsh, SGE; Fernandez-Vina, M; Mack, S; Hollenbach, J; Middleton, D; (2012) THE RARE HLA ALLELES PROJECT: EXTENDING THE NUMBER OF RESOURCES AND BIOINFORMATICS ANALYSIS. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 549). WILEY-BLACKWELL

Gardiner, C; (2012) Guidelines for Evaluation of Coagulation Analyzer and Coagulation Testing, in Laboratory Hematology Practice. In: UNSPECIFIED Wiley-Blackwell

Gardiner, C; (2012) Guidelines for Evaluation of Coagulation Analyzers and Coagulation Testing. In: Laboratory Hematology Practice. (pp. 543-551).

Gardiner, C; Dragovic, R; Tannetta, D; Harrison, P; Redman, C; Sargent, I; (2012) CHARACTERISATION OF EXTRACELLULAR VESICLES BY MULTI-PARAMETER NANOPARTICLE TRACKING ANALYSIS. Presented at: UNSPECIFIED.

Germain, DP; Giugliani, R; Hughes, DA; Mehta, A; Nicholls, K; Barisoni, L; Jennette, CJ; ... Boudes, PF; + view all (2012) Safety and pharmacodynamic effects of a pharmacological chaperone on alpha-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies. ORPHANET JOURNAL OF RARE DISEASES , 7 (ARTN 91) 10.1186/1750-1172-7-91. Gold open access

Ghorashian, S; Carpenter, B; Holler, A; Nicholson, E; Ahmadi, M; Zech, M; Bennett, C; ... Chakraverty, R; + view all (2012) CD4 Cells Engineered to Express an MHC Class I Restricted TCR Can Rescue CD8 Cells Tolerized to Tumour-Associated Antigens. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Ghorashian, S; Holler, A; Carpenter, B; Ahmadi, M; Nicholson, E; Zech, M; Xue, SA; ... Chakraverty, R; + view all (2012) CD4 cells expressing an MHC class I restricted TCR can rescue CD8 cells tolerized to tumour-associated antigen. In: (Proceedings) European Congress of Immunology. (pp. p. 707). WILEY-BLACKWELL

Ghorashian, S; Holler, A; Flutter, B; Xue, S-A; Fallah-Arani, F; Sivakumaran, J; Bennett, C; ... Chakraverty, R; + view all (2012) CD4 help can overcome tolerance developing in adoptively-transferred T cells transduced with a self-specific TCR. In: (Proceedings) Annual Conference of the British-Society-for-Gene-Therapy (BSGT). (pp. A6-A6). MARY ANN LIEBERT INC

Giest, S; McWhinnie, A; Lefranc, M-P; Little, A-M; Grace, S; Mackinnon, S; Madrigal, JA; (2012) Cytomegalovirus-specific CD8+T cells targeting different peptide/HLA combinations demonstrate varying T-cell receptor diversity. IMMUNOLOGY , 135 (1) pp. 27-39. 10.1111/j.1365-2567.2011.03508.x.

Giles, I; Khamashta, M; D'Cruz, D; Cohen, H; (2012) 'A new dawn of anticoagulation for patients with antiphospholipid syndrome?'. LUPUS , 21 (12) pp. 1263-1265. 10.1177/0961203312458843.

Gissel, M; Orfeo, T; Foley, JH; Butenas, S; (2012) Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. Thrombosis Research , 130 (6) pp. 948-955. 10.1016/j.thromres.2012.08.299.

Gisselbrecht, C; Schmitz, N; Mounier, N; Gill, DS; Linch, DC; Trneny, M; Bosly, A; ... Glass, B; + view all (2012) Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial in Relapsed Aggressive Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , 30 (36) pp. 4462-4469. 10.1200/JCO.2012.41.9416.

Giugliani, R; Boudes, P; Germain, DP; Fernhoff, P; Nichols, K; Hughes, D; Mehta, A; ... Sitaraman, S; + view all (2012) Evaluation of Globotriaosylceramide (GL-3) Accumulation in 18 Patients with Fabry Disease Nephropathy. Podocytes are More Severely Affected than Peritubular Capillaries. Presented at: 8th Annual World Symposium of the Lysosomal Disease Network, San Diego, CA.

Glassford, J; Kassen, D; Quinn, J; Stengel, C; Kallinikou, K; Khwaja, A; Yong, KL; (2012) Inhibition of cell cycle progression by dual phosphatidylinositol-3-kinase and mTOR blockade in cyclin D2 positive multiple myeloma bearing IgH translocations. BLOOD CANCER JOURNAL , 2 (ARTN e50) 10.1038/bcj.2011.44. Gold open access

Goodeve, AC; Perry, DJ; Cumming, T; Hill, M; Jennings, I; Kitchen, S; Walker, I; ... Tuddenham, E; + view all (2012) Genetics of haemostasis. HAEMOPHILIA , 18 pp. 73-80. 10.1111/j.1365-2516.2012.02832.x.

Green, CL; (2012) Studies on CEBPA mutations in acute myeloid leukaemia. Doctoral thesis , UCL (University College London). Green open access
file

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; MacKie, IJ; Chitolie, A; Haddad, FS; (2012) The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters. Thrombosis Research , 130 (5) pp. 775-779. 10.1016/j.thromres.2011.12.023.

Green, L; Lawrie, AS; Patel, R; Stephens, RCM; Mackie, IJ; Chitolie, A; Haddad, FS; (2012) The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters. THROMBOSIS RESEARCH , 130 (5) pp. 775-779. 10.1016/j.thromres.2011.12.023.

Green, L; Safa, O; Machin, SJ; Mackie, IJ; Ryland, K; Cohen, H; Lawrie, AS; (2012) Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway. THROMBOSIS RESEARCH , 130 (5) pp. 780-784. 10.1016/j.thromres.2011.12.034.

Griffin, J; Carpenter, B; Nicholson, E; Ghorasian, S; Holler, A; Velica, P; Xue, S; (2012) Gaining an advantage: mycophenolate-resistance for adoptively transferred cells. In: (Proceedings) European Congress of Immunology. (pp. p. 742). WILEY-BLACKWELL

Griffin, JE; Carpenter, B; Nicholson, E; Xue, S-A; Pule, M; Stauss, H; Chakraverty, R; (2012) In Vivo Selection of Mycophenolate Mofetil-Resistant T Cells for Adoptive Immunotherapy. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

H

Hammond, JA; Marsh, SGE; Robinson, J; Davies, CJ; Stear, MJ; Ellis, SA; (2012) Cattle MHC nomenclature: is it possible to assign sequences to discrete class I genes? IMMUNOGENETICS , 64 (6) pp. 475-480. 10.1007/s00251-012-0611-7.

Harrison, P; Gardiner, C; (2012) Invisible vesicles swarm within the iceberg. JOURNAL OF THROMBOSIS AND HAEMOSTASIS , 10 (5) pp. 916-918. 10.1111/j.1538-7836.2012.04711.x.

Heneghan, C; Ward, A; Perera, R; Bankhead, C; Fuller, A; Stevens, S; Bradford, K; ... The Self-Monitoring Trialist Collaboration, ; + view all (2012) Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. The Lancet , 379 (9813) pp. 322-334. 10.1016/S0140-6736(11)61294-4. Green open access
file

Hockings, C; Peggs, K; (2012) Life after allogeneic bone marrow transplant. BRITISH JOURNAL OF HOSPITAL MEDICINE , 73 (6) C93-C96. 10.12968/hmed.2012.73.Sup6.C93.

Hollak, CEM; Kuter, D; Giraldo, P; Hughes, D; Belmatoug, N; Brand, M; Muller, A; ... Zimran, A; + view all (2012) MIGLUSTAT THERAPY IN TYPE 1 GAUCHER DISEASE: LONG-TERM TREATMENT EXPERIENCE FROM A MULTICENTER, RETROSPECTIVE COHORT STUDY. Presented at: UNSPECIFIED.

Hollenbach, JA; Madbouly, A; Gragert, L; Vierra-Green, C; Flesch, S; Spellman, S; Begovich, A; ... Maiers, M; + view all (2012) A combined DPA1∼DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer. Immunogenetics pp. 1-11.

Holman, R; Marsh, SGE; Madrigal, JA; Chenery, P; Gomez, S; Latham, K; (2012) THE EFFECT OF INCORPORATING NON-INHERITED MATERNAL ANTIGENS INTO CORD DONOR SEARCH ALGORITHMS. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 454). WILEY-BLACKWELL

Hughes, D; Deegan, P; Romero, B; Hollak, C; Giugliani, R; (2012) Pregnancy Events in Females with Fabry Disease in the Fabry Outcome Survey. Presented at: 8th Anuual Research Meeting of the WORLD Symposium on Lysosomal Disease Networks, San Diego, CA.

Huq, FY; Kulkarni, A; Agbim, EC; Riddell, A; Tuddenham, E; Kadir, RA; (2012) Changes in the levels of factor VIII and von Willebrand factor in the puerperium. HAEMOPHILIA , 18 (2) pp. 241-245. 10.1111/j.1365-2516.2011.02625.x.

Hurley, CK; Wang, T; Spellman, SR; Umejiego, J; Aljurf, M; Askar, M; Battiwalla, M; ... Woolfrey, A; + view all (2012) IMPACT OF HLA UNIDIRECTIONAL MISMATCHES ON THE OUTCOME OF UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 407). WILEY-BLACKWELL

I

Illingworth, C; Michael, AJ; (2012) Plant ornithine decarboxylase is not post-transcriptionally feedback regulated by polyamines but can interact with a cytosolic ribosomal protein S15 polypeptide. AMINO ACIDS , 42 (2-3) pp. 519-527. 10.1007/s00726-011-1029-5.

J

Jenkinson, S; Koo, K; Goulden, N; Vora, A; Mitchell, C; Wade, R; Richards, SM; ... Gale, RE; + view all (2012) Presence of mutations in the NOTCH1 signalling pathway has a beneficial impact on outcome in paediatric T-ALL patients treated on the MRC UKALL2003 trial. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 19-20). WILEY-BLACKWELL

Jorgensen, M; Cheng, D; Goulden, N; Vora, A; Shankar, A; Hough, R; Grandage, V; (2012) LOW EFFICACY OF ROUTINE CSF SURVEILLANCE IN DETECTING ASYMPTOMATIC CNS RELAPSE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA. In: (pp. p. 973). WILEY PERIODICALS, INC

Jorgensen, M; Shankar, A; Aabideen, Z; Cheng, D; Goulden, N; Vora, A; Grandage, V; ... Samarasinghe, S; + view all (2012) The role of routine surveillance for silent central nervous system relapse in children with acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 159 (3) pp. 368-370. 10.1111/bjh.12021.

K

Kallinikou, K; Anjos-Afonso, F; Blundell, MP; Ings, SJ; Watts, MJ; Thrasher, AJ; Linch, DC; ... Yong, KL; + view all (2012) Engraftment defect of cytokine-cultured adult human mobilized CD34(+) cells is related to reduced adhesion to bone marrow niche elements. BRITISH JOURNAL OF HAEMATOLOGY , 158 (6) pp. 778-787. 10.1111/j.1365-2141.2012.09219.x.

Kammertoens, T; Qin, Z; Briesemeister, D; Bendelac, A; Blankenstein, T; (2012) B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin). Int J Cancer , 131 (7) pp. 1499-1508. 10.1002/ijc.27411.

Karwacz, K; Arce, F; Bricogne, C; Kochan, G; Escors, D; (2012) PD-L1 co-stimulation, ligand-induced TCR down-modulation and anti-tumor immunotherapy. ONCOIMMUNOLOGY , 1 (1) pp. 86-88. 10.4161/onci.1.1.17824.

Keeling, D; Mackie, I; Moore, GW; Greer, IA; Greaves, M; (2012) Guidelines on the investigation and management of antiphospholipid syndrome. BRITISH JOURNAL OF HAEMATOLOGY , 157 (1) pp. 47-58. 10.1111/j.1365-2141.2012.09037.x.

Keeling, D; Mackie, I; Moore, GW; Greer, IA; Greaves, M; (2012) Guidelines on the investigation and management of antiphospholipid syndrome. British Journal of Haematology , 157 (1) pp. 47-58. 10.1111/j.1365-2141.2012.09037.x.

Keeling, L; Suvarna, SK; Hughes, DA; (2012) Female Anderson-Fabry disease mimicking hypertrophic cardiomyopathy. JOURNAL OF CLINICAL PATHOLOGY , 65 (4) pp. 377-378. 10.1136/jclinpath-2011-200166.

Kepp, O; Menger, L; Vacchelli, E; Adjemian, S; Martins, I; Ma, Y; Sukkurwala, AQ; ... Kroemer, G; + view all (2012) Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects. Oncoimmunology , 1 (9) pp. 1640-1642. 10.4161/onci.21684.

Knight, A; Arnouk, H; Gillespie, G; Britt, W; Su, Y; Lowdell, MW; Lamb, LS; (2012) CYTOMEGALOVIRUS-INDEPENDENT LYSIS OF GLIOMA-DERIVED CELL LINES AND PRIMARY TUMOR EXPLANTS BY IN VITRO EXPANDED/ACTIVATED V Delta 1+Gamma Delta T CELLS. In: (Proceedings) 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO). (pp. p. 38). OXFORD UNIV PRESS INC

Knight, A; Mackinnon, S; Lowdell, MW; (2012) Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. CYTOTHERAPY , 14 (9) pp. 1110-1118. 10.3109/14653249.2012.700766.

Kwiatkowski, JL; Kim, H-Y; Thompson, AA; Quinn, CT; Mueller, BU; Odame, I; Giardina, PJ; ... Neufeld, EJ; + view all (2012) Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. BLOOD , 119 (12) pp. 2746-2753. 10.1182/blood-2011-04-344507.

L

Lambertsen, KL; Anthony, DC; Couch, Y; Martin, NA; Ormhoj, M; Schmidt, M-LB; Deierborg, T; ... Clausen, BH; + view all (2012) Anti-TNF therapy improves behavioural outcomes after focal cerebral ischemia in mice. In: (Proceedings) 11th International Congress of Neuroimmunology (ISNI). (pp. p. 101). ELSEVIER SCIENCE BV

Last, V; Williams, A; Werling, D; (2012) Inhibition of cytosolic Phospholipase A(2) prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin. BMC NEUROSCIENCE , 13 (ARTN 106) 10.1186/1471-2202-13-106. Gold open access

Laufer, J; Jathoul, A; Johnson, P; Zhang, E; Lythgoe, M; Pedley, RB; Pule, M; (2012) In vivo photoacoustic imaging of tyrosinase expressing tumours in mice. PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2012 , 8223 (ARTN 822) 10.1117/12.907006.

Lawrie, AS; Hills, J; Longair, I; Green, L; Gardiner, C; MacHin, SJ; Cohen, H; (2012) The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients. Thrombosis Research , 130 (1) pp. 110-114. 10.1016/j.thromres.2011.08.027.

Lawrie, AS; Hills, J; Longair, I; Green, L; Gardiner, C; Machin, SJ; Cohen, H; (2012) The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients. THROMBOSIS RESEARCH , 130 (1) pp. 110-114. 10.1016/j.thromres.2011.08.027.

Lawrie, AS; Pizzey, A; Trompeter, S; Meiselman, H; Mohandas, N; Dumanski, JP; Westerman, MP; (2012) Procoagulant activity in patients with sickle cell trait. BLOOD COAGULATION & FIBRINOLYSIS , 23 (4) pp. 268-270. 10.1097/MBC.0b013e32835187f8.

Lee, L; Fielding, AK; (2012) Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia. Clin Med Insights Oncol , 6 pp. 85-100. 10.4137/CMO.S7262. Gold open access

Loosemore, M; Walsh, SB; Morris, E; Stewart, G; Porter, JB; Montgomery, H; (2012) Sudden exertional death in sickle cell trait. BRITISH JOURNAL OF SPORTS MEDICINE , 46 (5) pp. 312-314. 10.1136/bjsports-2011-090521.

Lotta, LA; Wu, HM; Mackie, IJ; Noris, M; Veyradier, A; Scully, MA; Remuzzi, G; ... Peyvandi, F; + view all (2012) Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura. BLOOD , 120 (2) pp. 440-448. 10.1182/blood-2012-01-403113.

Lowdell, MW; (2012) Natural Killer T cells - balancing the regulation of tumor immunity. Br J Cancer , 107 (10) pp. 1795-1796. 10.1038/bjc.2012.453.

Lowdell, MW; Birchall, M; Thrasher, AJ; (2012) Use of compassionate-case ATMP in preclinical data for clinical trial applications. LANCET , 379 (9834) p. 2341. 10.1016/S0140-6736(12)61018-6.

Lowdell, MW; Samuel, E; (2012) Processing of Cells for Transplantation. In: Tissue and Cell Processing: An Essential Guide. (pp. 271-292).

Lown, RN; Shaw, BE; (2012) 'First do no harm': where do we stand on unrelated hematopoietic cell donor safety? Expert Rev Hematol , 5 (3) pp. 249-252. 10.1586/ehm.12.22.

Luevano, M; Daryouzeh, M; Alnabhan, R; Querol, S; Khakoo, S; Madrigal, A; Saudemont, A; (2012) The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. HUMAN IMMUNOLOGY , 73 (3) pp. 248-257. 10.1016/j.humimm.2011.12.015.

Luevano, M; Madrigal, A; Saudemont, A; (2012) Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy. CELLULAR & MOLECULAR IMMUNOLOGY , 9 (4) pp. 310-320. 10.1038/cmi.2012.17.

Luevano, M; Madrigal, A; Saudemont, A; (2012) Transcription factors involved in the regulation of natural killer cell development and function: an update. FRONTIERS IN IMMUNOLOGY , 3 (ARTN 319) 10.3389/fimmu.2012.00319.

M

Maharaj, L; Popat, R; Gribben, JG; Joel, S; (2012) IL-6, IL-8 and VEGF Neutralisation Restores Drug Sensitivity to Conventional and Novel Treatment Combinations in a Multiple Myeloma Bone Marrow Micro-Environment Model. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Majumder, B; (2012) An investigation into the role of platelet- monocyte interaction and inflammation in coronary artery disease. Doctoral thesis , UCL (University College London). Green open access
file

Majumder, B; North, J; Mavroudis, C; Rakhit, R; Lowdell, MW; (2012) Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategy. Cytometry Part B - Clinical Cytometry , 82 B (6) pp. 353-359. 10.1002/cyto.b.21040.

Majumder, B; North, J; Mavroudis, C; Rakhit, R; Lowdell, MW; (2012) Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategy. Cytometry B Clin Cytom , 82 (6) pp. 353-359. 10.1002/cyto.b.21040.

Majumder, B; North, J; Mavroudis, C; Rakhit, R; Lowdell, MW; (2012) Toward new insights on the white blood cell differential by flow cytometry: A proof of concept study on the sepsis model. CYTOMETRY PART B-CLINICAL CYTOMETRY , 82B (6) pp. 353-359. 10.1002/cyto.b.21027.

Malam, Y; Tsui, J; El Sheikh, S; Tuddenham, EGD; Baker, DM; (2012) Haemophilic pseudotumour of the carotid artery. VASCULAR MEDICINE , 17 (3) pp. 193-194. 10.1177/1358863X11429998.

Marquardt, L; Baker, R; Segal, H; Burgess, AI; Poole, D; Hughes, DA; Rothwell, PM; (2012) Fabry disease in unselected patients with TIA or stroke: population-based study. EUROPEAN JOURNAL OF NEUROLOGY , 19 (11) pp. 1427-1432. 10.1111/j.1468-1331.2012.03739.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update April 2012. TISSUE ANTIGENS , 80 (3) pp. 280-285. 10.1111/j.1399-0039.2012.01945.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update April 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 532-537. 10.1111/j.1744-313X.2012.01148.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update August 2012. TISSUE ANTIGENS , 80 (6) pp. 560-563. 10.1111/tan.12031.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update December 2011. TISSUE ANTIGENS , 79 (3) pp. 230-234. 10.1111/j.1399-0039.2012.01841.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update December 2011. HUMAN IMMUNOLOGY , 73 (4) pp. 435-438. 10.1016/j.humimm.2012.01.003.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update December 2011*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 275-278. 10.1111/j.1744-313X.2012.01100.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update February 2012. TISSUE ANTIGENS , 80 (1) pp. 72-77. 10.1111/j.1399-0039.2012.01882.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update February 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (4) pp. 365-369. 10.1111/j.1744-313X.2012.01127.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update February 2012. Human Immunology , 73 (7) pp. 767-771. 10.1016/j.humimm.2012.04.001.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update January 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (5) pp. 454-457. 10.1111/j.1744-313X.2012.01109.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update July 2012. TISSUE ANTIGENS , 80 (6) pp. 555-559. 10.1111/tan.12030.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update June 2012. TISSUE ANTIGENS , 80 (3) pp. 289-293. 10.1111/j.1399-0039.2012.01947.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update June 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 541-545. 10.1111/j.1744-313X.2012.01150.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update March 2012. TISSUE ANTIGENS , 80 (2) pp. 202-204. 10.1111/j.1399-0039.2012.01888.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update March 2012. HUMAN IMMUNOLOGY , 73 (8) pp. 867-869. 10.1016/j.humimm.2012.04.002.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update March 2012*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (4) pp. 370-372. 10.1111/j.1744-313X.2012.01128.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update May 2012. TISSUE ANTIGENS , 80 (3) pp. 286-288. 10.1111/j.1399-0039.2012.01946.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update May 2012. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 538-540. 10.1111/j.1744-313X.2012.01149.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update November 2011. TISSUE ANTIGENS , 79 (3) pp. 222-229. 10.1111/j.1399-0039.2012.01840.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update November 2011. HUMAN IMMUNOLOGY , 73 (3) pp. 320-325. 10.1016/j.humimm.2012.01.002.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update November 2011*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 268-274. 10.1111/j.1744-313X.2012.01099.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update October 2011. TISSUE ANTIGENS , 79 (3) pp. 218-221. 10.1111/j.1399-0039.2012.01839.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update October 2011. HUMAN IMMUNOLOGY , 73 (4) pp. 432-434. 10.1016/j.humimm.2012.01.001.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update October 2011*. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (3) pp. 264-267. 10.1111/j.1744-313X.2012.01098.x.

Marsh, SGE; (2012) Nomenclature for factors of the HLA system, update September 2012. TISSUE ANTIGENS , 80 (6) pp. 564-569. 10.1111/tan.12034.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2012) Nomenclature for factors of the HLA system, update January 2012. Tissue Antigens , 79 (5) pp. 393-397. 10.1111/j.1399-0039.2012.01856.x.

Martins, I; Michaud, M; Sukkurwala, AQ; Adjemian, S; Ma, Y; Shen, S; Kepp, O; ... Kroemer, G; + view all (2012) Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy , 8 (3) pp. 413-415. 10.4161/auto.19009.

Marzolini, M; Dorman, J; O'Leary, C; Thomson, K; D'Sa, S; (2012) Autologous stem cell transplantation can improve the quality of response in lymphoplasmacytic lymphoma/waldenstrom macroglobulinaemia with a median time to best response of 5 months. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 86). WILEY-BLACKWELL

Marzolini, M; Wong, WL; Ardeshna, K; Padhani, A; D'Sa, S; (2012) Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma. Br J Haematol , 156 (5) 557-. 10.1111/j.1365-2141.2011.08959.x.

Marzolini, MAV; Poggiali, E; Badat, M; Cassinerio, E; Cappellini, MD; Porter, JB; (2012) Spinal Artery Thrombosis: An Unrecognized Severe Complication in Thalassemia and Sickle Disorders. In: (pp. p. 1155).

Mattar, CN; Waddington, SN; Biswas, A; Davidoff, AM; Choolani, M; Chan, JKY; Nathwani, AC; (2012) The case for intrauterine gene therapy. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY , 26 (5) pp. 697-709. 10.1016/j.bpobgyn.2012.06.006.

Mavroudis, CA; Eleftheriou, D; Majumder, B; Sapsford, R; North, J; Lowdell, M; Brogan, P; (2012) DEMONSTRATION OF INTRACORONARY MICROPARTICLE EXPRESSION AND THEIR ASSOCIATION WITH ACTIVATED PLATELET MONOCYTE AGGREGATE IN HUMAN ST ELEVATION MYOCARDIAL INFARCTION. In: (Proceedings) Annual Conference of the British-Cardiovascular-Society (BCS). (pp. A71-A72). B M J PUBLISHING GROUP

Mayor, NP; Shaw, BE; Madrigal, JA; Marsh, SGE; (2012) NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome. Bone Marrow Res , 2012 180391-. 10.1155/2012/180391.

McIntosh, JH; Cochrane, M; Cobbold, S; Waldmann, H; Nathwani, SA; Davidoff, AM; Nathwani, AC; (2012) Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. GENE THERAPY , 19 (1) pp. 78-85. 10.1038/gt.2011.64.

McIntosh, JH; Cochrane, M; Cobbold, S; Waldmann, H; Nathwani, SA; Davidoff, AM; Nathwani, AC; (2012) Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine. Gene Therapy , 19 (1) pp. 78-85. 10.1038/gt.2011.64.

McNeill, A; Duran, R; Hughes, DA; Mehta, A; Schapira, AH; (2012) A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers. [Letter]. Journal of Neurology, Neurosurgery & Psychiatry , 83 (8) 853 -854. 10.1136/jnnp-2012-302402. Green open access
file

McNeill, A; Duran, R; Proukakis, C; Bras, J; Hughes, D; Mehta, A; Hardy, J; ... Schapira, AHV; + view all (2012) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. MOVEMENT DISORDERS , 27 (4) pp. 526-532. 10.1002/mds.24945.

Menger, L; Vacchelli, E; Adjemian, S; Martins, I; Ma, Y; Shen, S; Yamazaki, T; ... Kroemer, G; + view all (2012) Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med , 4 (143) 143ra99-. 10.1126/scitranslmed.3003807.

Milius, B; Schneider, J; Heuer, M; Bashyal, P; George, M; Schneyman, D; Pollack, J; ... Maiers, M; + view all (2012) TOOLS FOR IMPLEMENTATION OF SILVER STANDARD PRINCIPLES FOR HLA TYPING. In: (Proceedings) 38th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. p. 8). ELSEVIER SCIENCE INC

Miller, CE; Pang, H; Brian, D; Pang, K; North, J; Shah, F; O'Shea, J; ... McNamara, C; + view all (2012) Transition to an integrated reporting system for bone marrow biopsies from patients with suspected haematological malignancy - experience in North Central London/West Essex. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. pp. 28-29). WILEY-BLACKWELL

Mohamedbhai, SG; Edwards, N; Morris, EC; Mackinnon, S; Thomson, KJ; Peggs, KS; (2012) Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure. BRITISH JOURNAL OF HAEMATOLOGY , 156 (4) pp. 516-522. 10.1111/j.1365-2141.2011.08944.x.

Moore, S; Kayani, I; Peggs, K; Qian, W; Lowry, L; Thomson, K; Linch, DC; (2012) Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL. BRITISH JOURNAL OF HAEMATOLOGY , 157 (5) pp. 543-552. 10.1111/j.1365-2141.2012.09096.x.

Moore, S; Peggs, K; Thomson, K; Lowry, L; Ljubic, A; Goldstone, AH; Linch, DC; (2012) Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy. BRITISH JOURNAL OF HAEMATOLOGY , 156 (1) pp. 142-144. 10.1111/j.1365-2141.2011.08818.x.

Moorman, AV; Schwab, C; Ensor, HM; Russell, LJ; Morrison, H; Jones, L; Masic, D; ... Harrison, CJ; + view all (2012) IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic Leukemia. JOURNAL OF CLINICAL ONCOLOGY , 30 (25) pp. 3100-3108. 10.1200/JCO.2011.40.3907.

Morris, CR; Kim, H-Y; Wood, JC; Trachtenberg, F; Klings, ES; Porter, JB; Sweeters, N; ... Kuypers, FA; + view all (2012) Cardiopulmonary and Laboratory Profiling of Patients with Thalassemia At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Morris, CR; Kim, H-Y; Wood, JC; Trachtenberg, F; Klings, ES; Porter, JB; Sweeters, N; ... Vichinsky, E; + view all (2012) Sildenafil Therapy in Patients with Thalassemia and an Elevated Tricuspid Regurgitant Jet Velocity (TRV) On Doppler Echocardiography At Risk for Pulmonary Hypertension: Report From the Thalassemia Clinical Research Network. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Musallam, KM; Porter, JB; Soweid, A; Hoballah, JJ; Sfeir, PM; Khalife, M; Zeineldine, S; ... Jamali, FR; + view all (2012) Elevated Hematocrit Concentration and the Risk of Mortality and Vascular Events in Patients Undergoing Major Surgery. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Musallam, KM; Porter, JB; Soweid, A; Hoballah, JJ; Sfeir, PM; Khalife, M; Zeineldine, S; ... Jamali, FR; + view all (2012) Elevated Hematocrit Concentration and the Risk of Mortality and Vascular Events in Patients Undergoing Major Surgery. In:

N

Neufeld, EJ; Galanello, R; Viprakasit, V; Aydinok, Y; Piga, A; Harmatz, P; Forni, GL; ... Rienhoff, HY; + view all (2012) Aphase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload. BLOOD , 119 (14) pp. 3263-3268. 10.1182/blood-2011-10-386268.

Ngkelo, A; Meja, K; Yeadon, M; Adcock, I; Kirkham, PA; (2012) LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and G(i)alpha dependent PI-3kinase signalling. JOURNAL OF INFLAMMATION-LONDON , 9 (ARTN 1) 10.1186/1476-9255-9-1.

Nicholson, E; Mackinnon, S; Thomson, KJ; Sudak, J; Fielding, AK; Kottaridis, P; Peggs, KS; ... Chakraverty, R; + view all (2012) FAVORABLE OUTCOMES IN ELDERLY AND HIGH-RISK PATIENTS WITH AML AND MDS FOLLOWING T-CELL DEPLETED REDUCED INTENSITY CONDITIONED ALLOGENEIC STEM CELL TRANSPLANTATION. In: (Proceedings) BMT Tandem Meeting. (pp. S346-S347). ELSEVIER SCIENCE INC

Nicholson, E; Mackinnon, S; Thomson, KJ; Sudak, J; Fielding, AK; Kottaridis, P; Peggs, KS; ... Chakraverty, R; + view all (2012) Favorable outcomes in elderly and high-risk patients with AML and MDS following T-cell depleted reduced intensity conditioned allogeneic stem cell transplantation. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 3). WILEY-BLACKWELL

O

Oseni, A; Crowley, C; Lowdell, M; Birchall, M; Butler, PE; Seifalian, AM; (2012) Advancing nasal reconstructive surgery: The application of tissue engineering technology. Journal of Tissue Engineering and Regenerative Medicine , 6 (10) pp. 757-768. 10.1002/term.487.

Oseni, A; Crowley, C; Lowdell, M; Birchall, M; Butler, PE; Seifalian, AM; (2012) Advancing nasal reconstructive surgery: the application of tissue engineering technology. JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE , 6 (10) pp. 757-768. 10.1002/term.487.

Owczarek, D; Undas, A; Foley, JH; Nesheim, ME; Jabłonski, K; Mach, T; (2012) Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases. Journal of Crohn's and Colitis , 6 (1) pp. 13-20. 10.1016/j.crohns.2011.06.005.

P

Payne, EM; Virgilio, M; Narla, A; Sun, H; Levine, M; Paw, BH; Berliner, N; ... Khanna-Gupta, A; + view all (2012) L-leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. BLOOD , 120 (11) pp. 2214-2224. 10.1182/blood-2011-10-382986.

Payne, NL; Sun, G; Herszfeld, D; Tat-Goh, PA; Verma, PJ; Parkington, HC; Coleman, HA; ... Bernard, CCA; + view all (2012) Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis. PLoS ONE , 7 (4) e35093-e35093. 10.1371/journal.pone.0035093.

Peggs, KS; Quezada, SA; (2012) PD-1 blockade: promoting endogenous anti-tumor immunity. EXPERT REVIEW OF ANTICANCER THERAPY , 12 (10) pp. 1279-1282. 10.1586/ERA.12.109.

Pennell, DJ; Porter, JB; Cappellini, MD; Chan, LL; El-Beshlawy, A; Aydinok, Y; Ibrahim, H; ... Taher, A; + view all (2012) Deferasirox for up to 3 years leads to continued improvement of myocardial T2(star) in patients with beta-thalassemia major. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 97 (6) pp. 842-848. 10.3324/haematol.2011.049957.

Pennell, DJ; Porter, JB; Piga, A; Lai, Y; El-Beshlawy, A; Beloul, K; Elalfy, M; ... Aydinok, Y; + view all (2012) A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with beta-Thalassemia Major and Iron Overload (CORDELIA). In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Percy, LA; Moore, SE; Qian, W; Dorman, J; Rabin, N; Watts, M; Linch, DC; (2012) Re-infused lymphocyte dose does not influence disease control following upfront autologous stem cell transplantation for multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 157 (4) pp. 494-496. 10.1111/j.1365-2141.2011.09023.x.

Petit, L; Lhériteau, E; Weber, M; Le Meur, G; Deschamps, J-Y; Provost, N; Mendes-Madeira, A; ... Rolling, F; + view all (2012) Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy. Mol Ther , 20 (11) pp. 2019-2030. 10.1038/mt.2012.134.

Philip, B; Flutter, B; Chakraverty, R; Jathoul, A; Pule, M; (2012) A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy. In: (Proceedings) 15th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT). (pp. S35-S36). NATURE PUBLISHING GROUP

Pidala, J; Wang, T; Haagenson, MD; Spellman, S; Askar, M; Battiwalla, M; Baxter-Lowe, LA; ... Anasetti, C; + view all (2012) Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Porter, J; Bowden, DK; Economou, M; Troncy, J; Ganser, A; Habr, D; Martin, N; ... Cappellini, MD; + view all (2012) Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical Trial. Anemia , 2012 297641-. 10.1155/2012/297641.

Porter, JB; Elalfy, M; Viprakasit, V; Giraudier, S; Chan, LL; Lai, Y; El-Ali, A; ... Cappellini, MD; + view all (2012) Serum Ferritin, Labile Plasma Iron and Transferrin Saturation: Comparison Between Underlying Anemias with Transfusional Iron Overload Before and After Treatment with Deferasirox. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Porter, JB; Hershko, C; (2012) Clinical use of iron chelators. In: Iron Physiology and Pathophysiology in Humans. (pp. 591-627).

Porter, JB; Walter, PB; Neumayr, LD; Evans, P; Weyhmiller, MG; Harmatz, P; Wood, JC; ... Vichinsky, E; + view all (2012) Iron Trafficking and Distribution in Transfusional Overload: Insights From Comparing Diamond Blackfan Anemia with Sickle Cell Disease and Thalassemia. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Powell, F; McWhinnie, AJ; Tavarozzi, F; Madrigal, JA; Marsh, SGE; Latham, K; (2012) THE DESIGN OF A PCR-SSP PANEL TO REDUCE HLA TYPING AMBIGUITIES ARISING FROM OUR CURRENT LOCAL SEQUENCE BASED TYPING PROTOCOL. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 447). WILEY-BLACKWELL

R

Rabin, N; Percy, L; Khan, I; Quinn, J; D'Sa, S; Yong, KL; (2012) Improved response with post-ASCT consolidation by low dose thalidomide, cyclophosphamide and dexamethasone as first line treatment for multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 158 (4) pp. 499-505. 10.1111/j.1365-2141.2012.09188.x.

Rallapalli, P; Gomez, K; Tuddenham, E; Perkins, S; (2012) Phenotypic classification of the mutations in coagulation factor IXx segregate to different locations in its protein structure. HAEMOPHILIA , 18 p. 187.

Rea, CJ; Foley, JH; Sørensen, B; (2012) Factor XIII in the Treatment of Hemophilia A. New England Journal of Medicine , 366 (3) pp. 281-283. 10.1056/nejmc1113270.

Reading, JL; Meyers, AF; Vyakarnam, A; (2012) Whey acidic proteins (WAPs). Current Opinion in HIV and AIDS , 7 (2) pp. 172-179. 10.1097/COH.0b013e32835005d9.

Redman, C; Tannetta, D; Southcombe, J; Dragovic, B; Gardiner, C; Collett, G; Sargent, I; (2012) THE DANGEROUS PLACENTA AND PRE-ECLAMPSIA, A REVIEW. In: (Proceedings) Meeting of the International-Federation-of-Placenta-Associations (IFPA). (pp. A12-A12). W B SAUNDERS CO LTD

Redman, CWG; Tannetta, DS; Dragovic, RA; Gardiner, C; Southcombe, JH; Collett, GP; Sargent, IL; (2012) Review: Does size matter? Placental debris and the pathophysiology of pre-eclampsia. PLACENTA , 33 S48-S54. 10.1016/j.placenta.2011.12.006.

Robinson, J; Guethlein, LA; Halliwell, JA; Cereb, N; Marsh, SGE; Parham, P; (2012) IDENTIFICATION OF CORE HLA CLASS I ALLELES. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. pp. 550-551). WILEY-BLACKWELL

Robinson, J; Pollack, J; Walts, A; Schneider, J; Fritsch, R; Barber, A; Freeman, J; ... Marsh, SGE; + view all (2012) AN XML EXPORT OF THE IMGT/HLA DATABASE. In: (Proceedings) 38th Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. (pp. p. 167). ELSEVIER SCIENCE INC

Robinson, J; Pollack, J; Walts, A; Schneider, J; Fritsch, R; Barber, A; Freeman, J; ... Marsh, SGE; + view all (2012) AN XML EXPORT OF THE IMGT/HLA DATABASE. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. pp. 547-548). WILEY-BLACKWELL

Ryland, JK; Lawrie, AS; Mackie, IJ; Machin, SJ; (2012) Persistent high factor VIII activity leading to increased thrombin generation - A prospective cohort study. THROMBOSIS RESEARCH , 129 (4) pp. 447-452. 10.1016/j.thromres.2011.07.020.

S

Sabry, M; Lowdell, MW; (2012) Natural Killer Cell Responses to Tumor Priming. In: (Proceedings) 22nd Biennial Congress of the European-Association-for-Cancer-Research. (pp. S86-S86). ELSEVIER SCI LTD

Sack, BK; Merchant, S; Markusic, DM; Nathwani, AC; Davidoff, AM; Byrne, BJ; Herzog, RW; (2012) Transient B cell depletion or improved transgene expression by codon optimization promote tolerance to factor VIII in gene therapy. PLoS ONE , 7 (5) , Article e37671. 10.1371/journal.pone.0037671. Green open access
file

Sado, DM; Flett, AS; Banypersad, SM; White, SK; Maestrini, V; Quarta, G; Lachmann, RH; ... Moon, JC; + view all (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. HEART , 98 (19) pp. 1436-1441. 10.1136/heartjnl-2012-302346.

Samarasinghe, S; Steward, C; Hiwarkar, P; Saif, MA; Hough, R; Webb, D; Norton, A; ... Veys, P; + view all (2012) Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience. BRITISH JOURNAL OF HAEMATOLOGY , 157 (3) pp. 339-346. 10.1111/j.1365-2141.2012.09066.x.

Schellekens, J; Shaw, BE; Mayor, NP; Cooke, L; Madrigal, JA; Marsh, SGE; (2012) THE INFLUENCE OF PATIENT AND DONOR KIR HAPLOTYPES ON THE CLINICAL OUTCOME AFTER UNRELATED DONOR HSCT FOR PATIENTS SUFFERING FROM AML. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 467). WILEY-BLACKWELL

Sellar, RS; Peggs, KS; (2012) Management of multidrug-resistant viruses in the immunocompromised host. BRITISH JOURNAL OF HAEMATOLOGY , 156 (5) pp. 559-572. 10.1111/j.1365-2141.2011.08988.x.

Sellar, RS; Peggs, KS; (2012) Recent progress in managing graft-versus-host disease and viral infections following allogeneic stem cell transplantation. FUTURE ONCOLOGY , 8 (12) pp. 1549-1565. 10.2217/FON.12.153.

Sellar, RS; Peggs, KS; (2012) Therapeutic strategies for the prevention and treatment of cytomegalovirus infection. EXPERT OPINION ON BIOLOGICAL THERAPY , 12 (9) pp. 1161-1172. 10.1517/14712598.2012.693471.

Sellar, RS; Peggs, KS; (2012) The role of virus-specific adoptive T-cell therapy in hematopoietic transplantation. CYTOTHERAPY , 14 (4) pp. 391-400. 10.3109/14653249.2012.662769.

Sellar, RS; Ward, KN; Thomson, KJ; Peggs, KS; (2012) Evidence for clinical activity of artesunate in multidrug-resistant herpes simplex infection following HSCT. BONE MARROW TRANSPLANTATION , 47 (11) pp. 1482-1483. 10.1038/bmt.2012.46.

Shepherd, C; Banerjee, L; Cheung, CW; Mansour, MR; Jenkinson, S; Gale, RE; Khwaja, A; (2012) PI3K/mTOR Inhibition Upregulates NOTCH-MYC Signalling Leading to an Impaired Cytotoxic Response. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Sive, J; Ardeshna, KM; Cheesman, S; le Grange, F; Morris, S; Nicholas, C; Peggs, K; ... Goldstone, AH; + view all (2012) Hotel-based ambulatory care for complex cancer patients: A review of the University College London Hospital experience. LEUKEMIA & LYMPHOMA , 53 (12) pp. 2397-2404. 10.3109/10428194.2012.694430.

Sive, JI; Buck, G; Fielding, A; Lazarus, HM; Litzow, MR; Luger, S; Marks, DI; ... Goldstone, AH; + view all (2012) Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. BRITISH JOURNAL OF HAEMATOLOGY , 157 (4) pp. 463-471. 10.1111/j.1365-2141.2012.09095.x.

Sive, JI; Thomson, KJ; Morris, EC; Ward, KN; Peggs, KS; (2012) Adenoviremia Has Limited Clinical Impact in the Majority of Patients Following Alemtuzumab-Based Allogeneic Stem Cell Transplantation in Adults. CLINICAL INFECTIOUS DISEASES , 55 (10) pp. 1362-1370. 10.1093/cid/cis689.

Smith, BN; Evans, C; Ali, A; Ancliff, PJ; Hayee, B; Segal, AW; Hall, G; ... Gale, RE; + view all (2012) Phenotypic heterogeneity and evidence of a founder effect associated with G6PC3 mutations in patients with severe congenital neutropenia. BRITISH JOURNAL OF HAEMATOLOGY , 158 (1) pp. 146-149. 10.1111/j.1365-2141.2012.09110.x.

Snowden, JA; Pearce, RM; Lee, J; Kirkland, K; Gilleece, M; Veys, P; Clark, RE; ... Cook, G; + view all (2012) Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009. BRITISH JOURNAL OF HAEMATOLOGY , 157 (6) pp. 742-746. 10.1111/j.1365-2141.2012.09122.x.

Starke, RD; Paschalaki, KE; Ferraro, F; Dryden, NH; McKinnon, TAJ; Sutton, RE; Payne, EM; ... Randi, AM; + view all (2012) Endothelial Von Willebrand factor regulates angiogenesis. In: (Proceedings) 6th European Meeting on Vascular Biology and Medicine (EMVBM). (pp. pp. 318-319). ELSEVIER SCIENCE INC

Stengel, C; Cheung, CW; Quinn, J; Yong, K; Khwaja, A; (2012) Optimal induction of myeloma cell death requires dual blockade of phosphoinositide 3-kinase and mTOR signalling and is determined by translocation subtype. LEUKEMIA , 26 (8) pp. 1761-1770. 10.1038/leu.2012.69.

Straathof, K; Kokalaki, E; Philip, B; Himoudi, N; Pule, M; Anderson, J; (2012) T-CELLS GRAFTED WITH GD2-SPECIFIC ANTITUMOUR ACTIVITY: DEVELOPMENT OF IMMUNOTHERAPY FOR NEUROBLASTOMA. PEDIATRIC BLOOD & CANCER , 59 (6) p. 1006.

Sudres, M; Ciré, S; Vasseur, V; Brault, L; Da Rocha, S; Boisgérault, F; Le Bec, C; ... Galy, A; + view all (2012) MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV. Mol Ther , 20 (8) pp. 1571-1581. 10.1038/mt.2012.101.

Swerdlow, AJ; Cooke, R; Bates, A; Cunningham, D; Falk, SJ; Gilson, D; Hancock, BW; ... Williams, MV; + view all (2012) Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. J Clin Oncol , 30 (22) pp. 2745-2752. 10.1200/JCO.2011.38.8835.

Sørensen, B; Larsen, O; Rea, C; Tang, M; Foley, J; Fenger-Eriksen, C; (2012) Fibrinogen as a Hemostatic Agent. Seminars in Thrombosis and Hemostasis , 38 (03) pp. 268-273. 10.1055/s-0032-1309287.

T

Taher, AT; Porter, J; Viprakasit, V; Kattamis, A; Chuncharunee, S; Sutcharitchan, P; Siritanaratkul, N; ... Cappellini, MD; + view all (2012) Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. BLOOD , 120 (5) pp. 970-977. 10.1182/blood-2012-02-412692.

Theodoulou, A; Berryman, J; Nathwani, A; Scully, M; (2012) Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. TRANSFUSION AND APHERESIS SCIENCE , 46 (2) pp. 159-162. 10.1016/j.transci.2011.11.005.

Theodoulou, A; Berryman, J; Nathwani, A; Scully, M; (2012) Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia. Transfusion and Apheresis Science , 46 (2) pp. 159-162. 10.1016/j.transci.2011.11.005.

Thomson, KJ; Kottaridis, P; Cassoni, A; Morris, EC; Khwaja, A; Linch, DC; Chakraverty, R; ... Mackinnon, S; + view all (2012) ALLOGENEIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE MYELOID LEUKEMIA: NO INCREASE IN RELAPSE WITH ALEMTUZUMAB-DEPLETED GRAFTS. In: (Proceedings) BMT Tandem Meeting. (pp. S339-S340). ELSEVIER SCIENCE INC

Thomson, KJ; Mackinnon, S; Peggs, KS; (2012) CMV-specific cellular therapy for acute myeloid leukemia? BLOOD , 119 (4) pp. 1088-1090. 10.1182/blood-2011-10-383943.

Townsend, W; Linch, D; (2012) Hodgkin's lymphoma in adults. The Lancet , 380 (9844) pp. 836-847. 10.1016/S0140-6736(12)60035-X.

Townsend, WM; Johnson, RJ; Counsell, N; Shah, H; Pottinger, B; Evans, K; Wickham, C; ... Claudius, R; + view all (2012) A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Tuddenham, E; (2012) Development of genetics as a tool in bleeding disorder investigations during the 50-year development of the WFH. HAEMOPHILIA , 18 p. 101.

Tuddenham, E; (2012) Gene therapy for haemophilia B. HAEMOPHILIA , 18 pp. 13-17. 10.1111/j.1365-2516.2012.02823.x.

Tuddenham, E; (2012) Gene therapy for severe hemophilia B. HAEMOPHILIA , 18 p. 107.

Tuddenham, EG; (2012) "Magic" mushrooms don't cause renal failure. BMJ-BRITISH MEDICAL JOURNAL , 345 (ARTN e68) 10.1136/bmj.e6893.

U

Uttenthal, BJ; Carpenter, B; Ghorashian, S; Wright, GP; Flutter, B; Xue, SA; Chakraverty, R; (2012) Adoptive therapy with redirected MHC class I-restricted antigen-specific regulatory T cells is a potential novel cellular therapy for graft-versus-host disease. In: (Proceedings) 52nd Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 8). WILEY-BLACKWELL

V

Vacchelli, E; Galluzzi, L; Rousseau, V; Rigoni, A; Tesniere, A; Delahaye, N; Schlemmer, FDR; ... Kroemer, G; + view all (2012) Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer. Oncoimmunology , 1 (3) pp. 271-278. 10.4161/onci.18684.

Violi, F; Basili, S; Raparelli, V; Chowdary, P; Gatt, A; Burroughs, AK; (2012) Reply to: Platelet function in patients with cirrhosis. JOURNAL OF HEPATOLOGY , 56 (4) pp. 994-995. 10.1016/j.jhep.2011.09.006.

W

Wallis-Jones, S; McWhinnie, AJ; Madrigal, JA; Latham, K; Marsh, SGE; (2012) TEN NOVEL HLA-A AND HLA-DRB1 ALLELES IDENTIFIED THROUGH GROUP SPECIFIC AMPLIFICATION AT ANTHONY NOLAN. In: (Proceedings) Joint 16th International HLA and Immunogenetics Workshop/26th European Federation for Immunogenetics Conference/23rd British-Society-of-Histocompatibility-and-Immunogenetics Conference. (pp. p. 438). WILEY-BLACKWELL

Walter, PB; Harmatz, P; Higa, A; Ng, V; Weyhmiller, MG; Evans, P; Porter, JB; ... Vichinsky, E; + view all (2012) Innate Immune Cell Expression of Pattern Recognition Receptors From beta-Thalassemia Patients During Intensive Combination Chelation Therapy. In: (Proceedings) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). AMER SOC HEMATOLOGY

Y

Yang, KL; Chu, CC; Marsh, SGE; Lin, PY; (2012) HLA-A*11:53 is shown to be identical to the corrected A*11:02:01 allele sequence. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 39 (6) pp. 524-526. 10.1111/j.1744-313X.2012.01121.x.

Z

Zambetti, L.P.; (2012) Preparation and characterization of engineered antigen presenting cells (APCs) for the generation of cytotoxic response for transplantation-related immunotherapy. Doctoral thesis , UCL (University College London). Green open access
file

Zech, M; Velica, P; Holler, A; Chakraverty, R; Stauss, H; (2012) Manipulating mTOR to enhance T cell mediated tumour immunity in vivo. In: (Proceedings) Annual Conference of the British-Society-for-Gene-Therapy (BSGT). (pp. A16-A16). MARY ANN LIEBERT INC

Zhang, Y; Patel, B; Dey, A; Ghorani, E; Rai, L; Elham, M; Castleton, AZ; (2012) Attenuated, Oncolytic, but Not Wild-Type Measles Virus Infection Has Pleiotropic Effects on Human Neutrophil Function. JOURNAL OF IMMUNOLOGY , 188 (3) pp. 1002-1010. 10.4049/jimmunol.1102262.

This list was generated on Sun Jul 7 05:22:47 2019 BST.